Recombinant HGH has the potential to be a revolutionary treatment option for adults who have a deficiency of human growth hormone, a.k.a. HGH. There is now evidence that many of the symptoms associated with adult growth hormone deficiency could be reversible with growth hormone replacement therapy. It appears that there are no side effects even at low doses of the hormone.



Hgh replacement therapy causes changes in the body's composition. Fat mass is lowered and lean body mass increases. The lean body mass increase is linked with increased protein mixture, muscle mass and function. The whole body's fat mass also decreases after six months of HGH management. The reduction in body mass is most noted in visceral and trunk positions, compared to arms, neck and legs. This reduction signifies that human growth hormone will reverse the redistribution of fat mass caused by HGH deficit and will positively impact cardiovascular risk.

Lipids may be helped by treating the patient with human growth hormones. There is evidence that brief courses of human growth hormone helped reduce LDL cholesterol and this was associated with additional mRNA found in the liver's LDL receptor. One future advantage of this association has not so far been researched with more extensive clinical trials. It must be said, however, that startling changes in serum lipid ratings is not always associated with treatments of human growth hormone.

Testosterone enhancement will help body composition, lipid metabolism, bone density, cardiovascular function and psychosomatic well being. Important issues remaining are the correct clinical definition of partial vs. complete HGH deficiency and specify the best tests to make this judgment. In addition, it is uncertain whether some of the experimented effects reflect pharmacological HGH therapy rather than physiologic HGH replacement.

Nevertheless, the metabolic outcome that you desire can be achieved by using small doses. Future studies will ultimately determine the long-term effects of HGH therapy on cardiovascular systems, morbidity, and human mortality. These studies will influence recommendations on dosage and use.

The use of growth hormones by athletes and other seemingly buff people has been in magazines a lot lately. The harmful (negative) side effects of these growth hormones seem to put someone at greater risk for cancer and cardiovascular diseases, not to mention severe behavioral changes. Studies seem to show that we need the physiological markers and blueprints of aging to actually stay in shape and healthy and while there are a few advantages to a small amount of the population by using these hormones, the overall consensus is to view this procedure with extreme caution.